Scan to downloadDaito Pharmaceutical Co., Ltd. (4577) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-11-02 | Treasury Shares | Notice Regarding Repurchase of Own Shares | |
| 2026-10-14 | Earnings Release | [Summary] Summary of Consolidated Financial Results for the Three Months Ended August 31, 2026 (Under Japanese GAAP) | |
| 2026-10-14 | Presentation Materials | FY2027 1Q Earnings Presentation | |
| 2026-10-14 | Treasury Shares | Notice Concerning the Acquisition of Treasury Shares and the Cancellation of Treasury Shares | |
| 2026-09-30 | — | Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical's Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ | |
| 2026-07-15 | Presentation Materials | FY2026 4Q Earnings Presentation | |
| 2026-07-13 | Treasury Shares | Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3) |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.